Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges

Published on 14 Jan 2025 on Benzinga · via Yahoo Finance

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla,...

Read the rest of the article

Start tracking your investments with Statfolio

(Bloomberg) -- Pfizer Inc. sold about 700 million shares in Haleon Plc, representing a roughly 7....

Bloomberg · via Yahoo Finance 15 Jan 2025

Pfizer Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology,...

24/7 Wall St · via AOL 14 Jan 2025

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soare...

Insider Monkey · via Yahoo Finance 14 Jan 2025

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla,...

Benzinga · via Yahoo Finance 14 Jan 2025

Pfizer Inc. is offering around 700 million shares in Haleon Plc, representing a roughly 7.7% stak...

Bloomberg 14 Jan 2025

The investor should try to establish if the expected growth or decline in earnings, whichever the...

Simply Wall St. · via Yahoo Finance 14 Jan 2025

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Fun...

Insider Monkey · via Yahoo Finance 13 Jan 2025

Key Insights Significantly high institutional ownership implies Pfizer's stock price is sensitive...

Simply Wall St. · via Yahoo Finance 9 Jan 2025

We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, w...

Insider Monkey · via Yahoo Finance 3 Jan 2025

Research analysts discuss the latest news and events impacting stocks and the financial markets....

Zacks · via Yahoo Finance 3 Jan 2025